593.39MMarket Cap-0.28P/E (TTM)
18.220High16.600Low829.13KVolume17.720Open17.870Pre Close14.37MTurnover2.47%Turnover RatioLossP/E (Static)33.60MShares24.92052wk High0.23P/B593.39MFloat Cap12.33052wk Low--Dividend TTM33.60MShs Float24.920Historical High--Div YieldTTM9.07%Amplitude12.330Historical Low17.331Avg Price1Lot Size
Grail Stock Forum
Larger Image: tradingview.com...
$Grail (GRAL.US)$
GRAIL Advances the Galleri® Registrational Clinical Trial Program
GRAIL (NASDAQ: GRAL) has announced significant progress in its clinical trials for the Galleri® multi-cancer early detection (MCED) test. The company has completed enrollment of over 35,000 participants in the PATHFINDER 2 study across North America and finished the final study visits for the NHS-Galleri trial with more than 140,000 participants in England. Results from the first 25,000 PATHFINDER 2 participan...
No comment yet